載入...
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
Mevalonate kinase deficiency (MKD) is a severe autoinflammatory disease caused by recessive mutations in MVK resulting in reduced function of the enzyme mevalonate kinase, involved in the cholesterol/isoprenoid pathway. MKD presents with periodic episodes of severe systemic inflammation, poor qualit...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Limited
2018-01-01
|
| 叢編: | Case Reports in Pediatrics |
| 在線閱讀: | http://dx.doi.org/10.1155/2018/3514645 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|